Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0000899243-21-003872

Options or other derivatives

  • Chief Development Officer acquired 160,050 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hammond Janet MJ Chief Development Officer 2021-01-29 Grant or award · Stock Option (Right to Buy) +160,050 160,050 D: show line 1 in the form
Loading xslF345X03/doc4.xml…